180 related articles for article (PubMed ID: 23088680)
1. Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice.
Fitzpatrick LR; Small JS; Greene WH; Karpa KD; Farmer S; Keller D
Gut Pathog; 2012 Oct; 4(1):13. PubMed ID: 23088680
[TBL] [Abstract][Full Text] [Related]
2. Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice.
Fitzpatrick LR; Small JS; Greene WH; Karpa KD; Keller D
Gut Pathog; 2011 Oct; 3(1):16. PubMed ID: 22014083
[TBL] [Abstract][Full Text] [Related]
3. Bacillus coagulans GBI-30, 6086 (BC30) improves lactose digestion in rats exposed to a high-lactose meal.
Teichenné J; Catalán Ú; Mariné-Casadó R; Domenech-Coca C; Mas-Capdevila A; Alcaide-Hidalgo JM; Chomiciute G; Rodríguez-García A; Hernández A; Gutierrez V; Puiggròs F; Del Bas JM; Caimari A
Eur J Nutr; 2023 Sep; 62(6):2649-2659. PubMed ID: 37249602
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Bricker E; Garg R; Nelson R; Loza A; Novak T; Hansen J
Cochrane Database Syst Rev; 2005 Jan; (1):CD004610. PubMed ID: 15674956
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson R
Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
[TBL] [Abstract][Full Text] [Related]
6. Effects of Bacillus coagulans GBI-30, 6086 as an adjunct starter culture on the production of yogurt.
Cao J; Yu Z; Zhang Q; Yu L; Zhao J; Zhang H; Chen W; Zhai Q
Food Res Int; 2022 Oct; 160():111398. PubMed ID: 36076366
[TBL] [Abstract][Full Text] [Related]
7. Bacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1).
Keller D; Van Dinter R; Cash H; Farmer S; Venema K
Benef Microbes; 2017 May; 8(3):491-496. PubMed ID: 28504581
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
9. Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.
Nyangale EP; Farmer S; Cash HA; Keller D; Chernoff D; Gibson GR
J Nutr; 2015 Jul; 145(7):1446-52. PubMed ID: 25948780
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
Kokkotou E; Moss AC; Michos A; Espinoza D; Cloud JW; Mustafa N; O'Brien M; Pothoulakis C; Kelly CP
Antimicrob Agents Chemother; 2008 Mar; 52(3):1121-6. PubMed ID: 18195066
[TBL] [Abstract][Full Text] [Related]
11. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Clostridium difficile colitis and diarrhea with vancomycin.
Silva J; Batts DH; Fekety R; Plouffe JF; Rifkin GD; Baird I
Am J Med; 1981 Nov; 71(5):815-22. PubMed ID: 7304654
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile-associated diarrhea and colitis.
Gerding DN; Johnson S; Peterson LR; Mulligan ME; Silva J
Infect Control Hosp Epidemiol; 1995 Aug; 16(8):459-77. PubMed ID: 7594392
[TBL] [Abstract][Full Text] [Related]
15. Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.
Buggy BP; Fekety R; Silva J
J Clin Gastroenterol; 1987 Apr; 9(2):155-9. PubMed ID: 3571889
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination.
Erikstrup LT; Aarup M; Hagemann-Madsen R; Dagnaes-Hansen F; Kristensen B; Olsen KE; Fuursted K
BMJ Open Gastroenterol; 2015; 2(1):e000038. PubMed ID: 26568840
[TBL] [Abstract][Full Text] [Related]
18. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.
Louie TJ; Peppe J; Watt CK; Johnson D; Mohammed R; Dow G; Weiss K; Simon S; John JF; Garber G; Chasan-Taber S; Davidson DM;
Clin Infect Dis; 2006 Aug; 43(4):411-20. PubMed ID: 16838228
[TBL] [Abstract][Full Text] [Related]
19. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
[No Abstract] [Full Text] [Related]
20. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.
Buffie CG; Jarchum I; Equinda M; Lipuma L; Gobourne A; Viale A; Ubeda C; Xavier J; Pamer EG
Infect Immun; 2012 Jan; 80(1):62-73. PubMed ID: 22006564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
